UNSPSC 51385614: Aspirin calcium

This classification denotes a cyclooxygenase inhibitor with the molecular formula 2C9H7O4.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WOD7W0DGZS, chemically known as 2-(acetyloxy)benzoic acid calcium salt, but more generally known as aspirin calcium, which bears US NIH Compound Identifier 6247. European Medicines Agency schedules aspirin calcium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20435. Most nations, for tariff purposes, schedule aspirin calcium under HS 29182200.

Aspirin calcium bears US NLM identifiers UMLS ID C2006111 and NCI Concept Code C83539. SMILES: CC(=O)OC1CCCCC1C(=O)[O-].CC(=O)OC1CCCCC1C(=O)[O-].[CA+2].

UNSPSC 51385614 Aspirin calcium is a Commodity code that in practice shows limited alignment with recent state and local procurement activity. The single recent opportunity tagged to this code — Seminole County, Florida's IFB 60459723LAS — solicits Naloxone and Safe Drug Deactivation Systems, products outside the aspirin calcium scope. The mismatch suggests either a coding error in the opportunity record or a narrow and inconsistent application of this Commodity code in state and local procurement systems. State and local buyers do purchase pharmaceutical supplies and over-the-counter medications through formal competitive processes, but the available recent-opportunities block does not surface aspirin calcium or related analgesic products as an active procurement category.

Seminole County's Naloxone procurement (IFB posted June 30, 2026, with response deadline July 26, 2023) calls for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, delivered quarterly to the Seminole County Community Health Building in Sanford, Florida. The contract includes a two-year initial term with one-year renewal option, requires E-Verify compliance and drug-free workplace certification, and is potentially FEMA-funded. Beyond this single mismatched record from Florida, the source provides no additional recent opportunities, issuing bodies, or geographic spread data under this code. Business development professionals should verify whether aspirin calcium and related analgesics generate regular procurement activity at the state, county, or municipal level, as the current record set does not support an active pursuit strategy.